Research has observed the appearance of new moles as a potential side effect, and changes in moles may be linked to an increased risk of skin cancer
The amino acid sequence is the same compound that Novo Nordisk has published, but the research-grade material supplied here is not equivalent to any Health Canada-authorized semaglutide product, is not produced under the same regulatory framework, and is not a substitute for the authorized formulations
This phenomenon has been observed with several effective diabetes treatments, not just GLP-1s
Retatrutide Facts to Know Right Now As of April 9, 2026, retatrutide is still in Phase 3 trials and is not FDA-approved Lilly says it is legally available only inside Lilly clinical trials It is being studied as a once-weekly shot TRIUMPH-4 reported 28.7% average weight loss at 68 weeks on 12 mg TRANSCEND-T2D-1 reported 16.8% average weight loss at 40 weeks on 12 mg in adults with type 2 diabetes In TRIUMPH-4, tingling or burning skin was reported by 20.9% of people on 12 mg Lilly says more retatrutide results are expected over the next year The tracker basics stay simple: log the dose, mark the site, track symptoms, food, water, and weight Retatrutide may still be trial-only, but the weekly routine around it is real
The dose is gradually increased to optimize effectiveness and minimize side effects, similar to other medications in this class
Aim for 7000 to 10000 steps daily regardless of how you feel
